Hazelden Co-occurring Disorders Program (CDP): Medication Management Curriculum 4 This curriculum is a valuable resource for medical directors and clinicians. It contains vital, current information about the complex issues of medication management, including medication compliance and other psychological concerns of the patient. Issues of differential diagnosis, timing, indications, monitoring, dosage, tolerance and withdrawal, and other topics are considered in this component. Current evidence and consensus-based practices are provided to enable providers to make clinical decisions about medications and their prescription. While many people in peer support groups take psychotropic medication, stigma can still cause some to hide their medication use from others. These issues, and information about the benefits and risks of medications, are also addressed for the patient. "The Hazelden Co-occurring Disorders Program" was developed and authored by national leaders in the research and treatment of co-occurring disorders. The program authors are faculty members from Dartmouth Psychiatric Research Center, Department of Psychiatry, Community and Family Medicine Department, and Dartmouth Medical School. The Dartmouth Psychiatric Research Center developed and tested the Integrated Dual Disorder Treatment (IDDT) model, an established evidence-based practice designed for people with severe mental health disorders. "The Hazelden Co-occurring Disorders Program" draws upon the numerous randomized controlled trials using the IDDT model and adapts them for patients with non-severe mental health disorders.